Glutamatergic gliotransmission provides a stimulatory input to excitatory synapses in the hippocampal dentate gyrus. Here, we show that tumor necrosis factor-alpha (TNFa) critically controls this process. With constitutive TNFa present, activation of astrocyte P2Y1 receptors induces localized [Ca 2+ ] i elevations followed by glutamate release and presynaptic NMDA receptor-dependent synaptic potentiation. In preparations lacking TNFa, astrocytes respond with identical [Ca 2+
INTRODUCTION
There are several indications that glial cells participate in the physiological control of synaptic transmission and plasticity via the release of synaptically effective mediators, a process called gliotransmission (reviewed in Perea et al., 2009; Volterra and Meldolesi, 2005 ; see also Henneberger et al., 2010) . However, some studies fail to see synaptic regulation by glia and question the physiological relevance of gliotransmission (Agulhon et al., 2010; Fiacco et al., 2007; Petravicz et al., 2008) . We identified a positive astrocytic control at perforant path (PP)-granule cell (GC) synapses in the hippocampal dentate gyrus (Jourdain et al., 2007) . Firing of PP afferents triggers intracellular Ca 2+ ([Ca 2+ ] i ) elevations in nearby astrocytes of the dentate molecular layer (ML). Astrocytes respond robustly to trains of evoked action potentials, but are also activated by sparse endogenous PP firing activity occurring in the slices in the absence of external stimulation. Intriguingly, part of the synaptically evoked astrocytic [Ca 2+ ] i elevations are mediated by purinergic P2Y1 receptors (P2Y1R), which in the ML are expressed predominantly, if not exclusively, in astrocytes, notably in the processes surrounding excitatory synapses (Jourdain et al., 2007) . As a consequence of P2Y1R-dependent [Ca 2+ ] i elevation, glutamate is released from astrocytes via a mechanism which is sensitive to blockers of neuronal exocytosis (Domercq et al., 2006) and induces potentiation of excitatory transmission at PP-GC synapses. This glial glutamatergic control operates under physiological conditions, as its blockade reduces basal EPSC activity in GCs evoked by endogenous PP firing (Jourdain et al., 2007) and is mediated by a presynaptic mechanism involving stimulation of NR2B-containing NMDA receptors (NMDAR). Indeed, both functional and ultrastructural evidence indicates that such receptors are located presynaptically, in the extrasynaptic portion of excitatory nerve terminals making synapses onto GCs (Jourdain et al., 2007) ; for a review on presynaptic NMDAR (pre-NMDAR) see Corlew et al. (2008) . Interestingly, we found that presynaptic NR2B subunits generally face perisynaptic astrocytic processes containing groups of small vesicular organelles (synaptic-like microvesicles, SLMV; Bezzi et al., 2004; Jourdain et al., 2007) . In immunogold experiments, astrocytic SLMV were shown to contain glutamate and express proteins for uptake and release of the amino acid, including vesicular glutamate transporters (VGLUT) and the v-SNARE protein, VAMP3/cellubrevin (Bezzi et al., 2004; Jourdain et al., 2007) . In spite of this ultrastructural information, the modalities and the regulation of astrocytic glutamate release in situ remain largely undefined. Moreover, contradictory results on the capacity of astrocytic [Ca 2+ ] i elevations to trigger glutamatergic gliotransmission at CA3-CA1 synapses (Agulhon et al., 2010; Fellin et al., 2004; Fiacco et al., 2007; Henneberger et al., 2010; Perea and Araque, 2007) suggest that the process may have specific Ca 2+ requirements or even that additional unknown regulatory factors are involved (Hamilton and Attwell, 2010; Kirchhoff, 2010; Shigetomi et al., 2008; Tritsch and Bergles, 2007) . In this context, we reported that the cytokine TNFa exerts a potent control on P2Y1R-evoked Ca 2+ -dependent glutamate exocytosis in cultured astrocytes (Domercq et al., 2006) . Measures of glutamate release with a specific assay (Bezzi et al., 1998; Nicholls et al., 1987) detected a dramatic reduction of the P2Y1R-evoked release in astrocyte cultures lacking TNFa signaling. The mechanism by which TNFa achieves this effect and the relevance of the TNFa-dependent control to the astrocyte-dependent synaptic potentiation in situ are unknown. TNFa is mostly regarded as a ''proinflammatory'' cytokine, produced by and acting in the brain in response to infection, injury, or disease (Gosselin and Rivest, 2007; Wetherington et al., 2008) . However, TNFa is expressed also in the normal brain, albeit at much lower levels than during inflammatory reactions, and participates in homeostatic brain functions (Boulanger, 2009; Vitkovic et al., 2000) . In particular, constitutive TNFa has recently been implicated in control of the stability of neuronal networks in response to prolonged changes in activity via the phenomenon of synaptic scaling (Stellwagen and Malenka, 2006; Turrigiano, 2008) and plays a specific role in ocular dominance plasticity upon monocular visual deprivation (Kaneko et al., 2008) . The cytokine, released from astrocytes, was reported to strengthen excitatory synaptic transmission by promoting surface insertion of AMPA receptor (AMPAR) subunits (Bains and Oliet, 2007; Beattie et al., 2002; Stellwagen et al., 2005) . In the present study, we find that TNFa is also an obligatory factor for the induction of synaptically effective gliotransmission at GC synapses in the dentate gyrus, specifically controlling glutamate release from astrocytes. Notably, constitutive levels of the cytokine promote functional docking and rapid coordinated secretion of glutamatergic vesicles in cultured astrocytes. Indeed, TNFa most likely determines the kinetics of P2Y1R-dependent glutamate release in situ and the local extracellular concentration of the amino acid, a critical factor in the activation of pre-NMDAR and, ultimately, in the potentiation of GC synapses.
RESULTS

P2Y1R-Evoked Gliotransmission Increases mEPSC Activity in GC via Pre-NMDAR
To investigate the role of TNFa in astrocyte-dependent synaptic modulation in hippocampal dentate gyrus, we planned studies on Tnf À/À mice (Pasparakis et al., 1996) . Our previous work in rats established that purinergic P2Y1R, strongly expressed in astrocytic processes around GC synapses, respond to stimulation with the agonist 2-methylthioadenosine-5 0 -diphosphate (2Me-SADP, 10 mM) by inducing a highly reproducible increase in mEPSC frequency in GCs (Jourdain et al., 2007) . We therefore decided to utilize this stimulus paradigm and recorded mEPSCs from hippocampal dentate GCs in acute mouse hemibrain horizontal slices from P18-P23 mice. Recordings were performed 50-90 mm deep in the slices, where astrocytes and the patched GCs retained their integral tridimensional structures, as confirmed by two-photon imaging of cells fluorescently labeled with specific markers ( Figure 1A ). Initially, we used slices from wild-type (WT) mice and applied 2MeSADP either by bath perfusion or locally, within the volume of the recorded GC, via pressure ejection from a micropipette. In both cases the P2Y1R agonist increased mEPSC frequency in GCs (bath application: +37% ± 11%; p < 0.05; n = 14 cells; local application: +32% ± 10%, p < 0.05; n = 7 cells), with no effect on the amplitude or kinetics of the currents ( Figure 1B and see Figure S1 available online). The effect of the drug on mEPSC frequency was abolished in the presence of N6-methyl-2 0 -deoxyadenosine-3 0 ,5 0 -bisphosphate (MRS2179 10 mM; n = 7 cells), a P2Y1R blocker, confirming the specific involvement of this purinergic receptor subtype. MRS2179 per se had no effect on basal mEPSC frequency ( Figure 1C) . In order to verify the obligatory role of astrocyte [Ca 2+ ] i elevation in the 2MeSADP synaptic effect, we repeated P2Y1R stimulations upon intracellular dialysis of the Ca 2+ chelator 1,2-bis(2-aminophenoxy) ethane-N,N,N 0 ,N 0 -tetra-acetic acid (BAPTA, 10 mM) selectively into the astrocytes ( Figure 1D ). This treatment prevents [Ca 2+ ] i rise in several gap-junction-connected astrocytes surrounding the synapses on the dendritic arbor of the patched GC (Jourdain et al., 2007) . In this situation, 2MeSADP never induced an increase in mEPSC frequency (n = 8 cells; Figure 1E ). Finally, the 2MeSADP-evoked effect was found to depend on NMDAR activation. Thus, the increase in mEPSC frequency was abolished in the presence of ifenprodil (3 mM), a selective NR2B-containing NMDAR antagonist that per se had no effect on basal mEPSC frequency (n = 10 cells; Figure 1F ). In conclusion, these experiments show that (1) P2Y1R activation induces, in mice, a gliotransmission cascade and synaptic effect on GCs similar to those previously observed in rats (Jourdain et al., 2007) ; (2) this astrocytic modulatory pathway is not endogenously activated by TTX-independent spontaneous synaptic release events at GC synapses, as indicated by the fact that neither MRS2179, nor BAPTA, nor ifenprodil affected basal mEPSC frequency.
Gliotransmission Loses Synaptic Efficacy in the Absence of Constitutive TNFa
Next, we addressed the role of constitutive TNFa in astrocyteevoked synaptic modulation, by testing the effect of 2MeSADP stimulation in slices from Tnf À/À mice. In basal conditions, frequency and amplitude of the mEPSC events in GCs were comparable to those observed in WT mice ( Figure S2 ; Kaneko et al., 2008; Stellwagen and Malenka, 2006) . However, application of 2MeSADP failed to produce the expected increase in mEPSC frequency (+5% ± 13%; n = 8 cells; Figure 2A ), suggesting that the presence of TNFa is necessary for astrocytic P2Y1R-evoked synaptic modulation. To confirm that the defect observed in Tnf À/À mice is specifically due to the absence of the cytokine, we preincubated Tnf À/À slices with low picomolar concentrations of recombinant TNFa (60-150 pM). In this condition, while basal mEPSC frequency did not change (Tnf À/À : 1.62 ± 0.26 Hz, n = 29 cells; Tnf À/À + TNFa: 1.64 ± 0.19 Hz; n = 13 cells), 2MeSADP application induced a selective increase in the number of mEPSC events, similar to its effect in WT slices ( Figure 2B ; +51% ± 22%; p < 0.05; n = 13 cells). Interestingly, in initial experiments we used prolonged TNFa preincubations (1-4 hr), but we then found that 15 min in the presence of the cytokine were sufficient to reconstitute the 2MeSADP effect. Preincubation of Tnf À/À slices with TNFa produced a second type of effect, on the amplitude of the mEPSC events, which was slightly but significantly increased in basal condition (Tnf À/À : 6.07 ± 0.26 pA, n = 29 cells; Tnf À/À + TNFa: 7.87 ± 0.52 pA; p < 0.05; n = 13 cells), but not further modified by 2MeSADP application. This P2Y1R-independent effect is strongly reminiscent of the effect ascribed to the control of AMPAR trafficking by TNFa in WT mice (Stellwagen et al., 2005; Stellwagen and Malenka, 2006) . In a final set of experiments, we tested whether constitutive levels of endogenous TNFa control P2Y1R-dependent synaptic modulation in WT slices. To this end, we preincubated the slices with a scavenger for the cytokine, the soluble form of TNF receptor (sTNFR, 15 mg/ml). This manipulation, while not changing basal mEPSC activity (frequency: 1.70 ± 0.21 Hz; amplitude 6.49 ± 0.41 pA; n = 9 cells), fully prevented the stimulatory effect of 2MeSADP on mEPSC frequency (+6% ± 10%; n = 9 cells; Figure 2C ). Overall, these data demonstrate that constitutive levels of TNFa are necessary for effective P2Y1R-dependent gliotransmission at PP-GC synapses and call for an understanding of the underlying mechanism. (B) Top: representative whole-cell recording of mEPSC activity in a granule cell (À65 mV). Control: basal condition; 2MeSADP: bath application of the purinergic P2Y1R agonist, 2MeSADP (10 mM). Insets: representative mEPSC events for each condition (scale: 5 ms, 5 pA). Bottom: cumulative probability plots of the same experiment comparing mEPSC inter-event interval (IEI) and amplitude before (control, black dots) and during P2Y1R stimulation (2MeSADP, gray open dots). Plots are accompanied by histograms of mean mEPSC frequency and amplitude (n = 14 GCs). Noteworthy, in 10/14 GCs, 2MeSADP selectively increased mEPSC frequency (+ 50% ± 11%, p < 0.001), whereas in 4 it was without effect. (C) Top: mEPSC currents in a representative recording from a hippocampal GC during: the control period, bath application of the specific P2Y1R antagonist MRS2179 (10 mM), and subsequent application of 2MeSADP (10 mM) in the presence of MRS2179. In 7/7 tested GCs, 2MeSADP, in the presence of MRS2179, failed to increase mEPSC frequency. Bottom: histograms of mean values of frequency and amplitude in the three conditions. No statistical difference was detected. (D) Left: two-photon image showing a single astrocyte whole-cell clamped with an internal solution containing 10 mM BAPTA and the low molecular weight fluorophore, Alexa 594 (100 mM, red) and patch-clamp recording from a GC neuron filled with Alexa 488. After removal of the pipette, a number of astrocytes gap-junction-coupled to the patched one are dialyzed with the BAPTA-containing solution (19 in the shown example). Right: electrophysiological identification of a ''passive astrocyte'' displaying linear I/V curve in response to 20 mV depolarizing steps from -100 mV to +80 mV. (E) Top: representative traces of mEPSC activity recorded from a hippocampal GC after dialysis of the astrocytic syncytium with BAPTA (see Experimental Procedures for details on the protocol of these experiments and the controls performed). Application of 2MeSADP in these conditions does not produce any variation in the frequency or amplitude of the events. Bottom: histograms representing the corresponding mean values obtained from 8 recorded GCs. No statistical differences were detected. (F) Top: representative traces of mEPSC activity recorded from a GC during the control period, bath application of ifenprodil (3 mM), or of 2MeSADP (10 mM) in the presence of ifenprodil. Bottom: histograms show no variations in mean frequency or amplitude of mEPSCs in the presence of ifenprodil or of 2MeSADP + ifenprodil (n = 10 GCs). Statistics: one-way ANOVA + Scheffé test for multiple comparisons and paired t test; Error bars: SEM. See also Figure S1 . excitatory function occur locally in astrocytic processes apposed to PP-GC synapses (Chuquet et al., 2010) . We therefore specifically studied P2Y1R-evoked Ca 2+ signaling in astrocytic processes with two-photon microscopy and compared local Ca 2+ responses to agonist stimulation in WT and Tnf À/À slices.
Experiments were performed on individual passive dentate ML astrocytes (see also Figure 1D for electrophysiological profile) dialyzed with a solution containing a Ca 2+ indicator (Fluo-4 pentapotassium, 200 mM) and a Ca 2+ -insensitive morphological dye (Texas Red dextran 3000, TxR, 150 mM; Figure 3A ). Local Ca 2+ activity in individual astrocytic processes, expressed as DG/R, was analyzed upon extracting the process of interest from the rest of the TxR image and subdividing it in many contiguous subregions (SRs) of similar area (9.2 ± 0.83 mm 2 ; Figure 3A) by use of a custom-made program (see details in Experimental Procedures). Appropriate conditions for focal P2Y1R stimulation were set by controlling duration (5 ms), pressure (4 psi) and distance of delivery (3-8 mm) of 2MeSADP (10 mM) puffs from a pipette positioned in the vicinity of the monitored astrocytic process. In WT slices, this protocol of focal 2MeSADP application produced fast [Ca 2+ ] i elevations ( Figures 3B and 3C ), seen immediately after the stimulus (average time to peak: 0.82 ± 0.15 s, n = 10; Figure 3E ), that were spatially restrained to a few micrometers (on average 8.6 ± 0.9 mm 2 ; range 5-16 mm 2 ; n = 10) in the astrocytic process, normally corresponding to an individual SR. In a few cases, the signal also invaded contiguous SRs (range 27-55 mm 2 ; WT: n = 3). The specificity of these localized Ca 2+ events was confirmed by the fact that (1) identical puffs of buffer solution did not evoke any [Ca 2+ ] i elevation (n = 3); (2) 2MeSADP-induced events were abolished in the presence of the P2Y1R antagonist MRS2179 and restored upon its washout ( Figure 3D ). The characteristics of 2MeSADP-evoked events, including their fast kinetics ( Figure 3E ), are consistent with those of the P2Y1R-dependent events evoked in astrocyte processes by endogenous synaptic activity (Chuquet et al., 2010) . Importantly, when we repeated the experiments in Tnf À/À astrocytes, we could not (B) Experiments in Tnf À/À slices preincubated with 60-150 pM TNFa for periods ranging from 15 min to 4 hr. As shown by traces, cumulative plots and histograms, 2MeSADP selectively increased mEPSC frequency in GCs if TNFa was preadded to the Tnf À/À slices (n = 13 cells). The effect was observed in 10/13 cells (+65% ± 27%, p < 0.01), whereas 3 did not respond to the drug. *p < 0.05, paired t test. (C) Left, mEPSCs recordings from a WT slice where TNFa has been scavenged by sTNFR (1.5-2 hr, 15 mg/ml). P2Y1R stimulation in this condition does not modify synaptic activity. Right, cumulative distribution plots and histograms for mEPSCs frequency and amplitude average values before and upon 2MeSADP stimulation is slices incubated with sTNFR (n = 9). Statistics: unpaired t test; Error bars: SEM. See also Figure S2 .
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TNFa Controls the Astrocytic Input to Synapses find any significant difference in the Ca 2+ responses to 2MeSADP puffs with respect to WT astrocytes in any of the parameters analyzed, including percentage of responding processes, delay of the responses, their amplitude, and kinetics ( Figure 3E ; WT: n = 10, Tnf À/À : n = 9). These results show that TNFa does not control P2Y1R-dependent [Ca 2+ ] i elevations in astrocytic processes. Hence, lack of synaptic efficacy in Tnf À/À slices cannot be directly ascribed to a defect in the P2Y1R-dependent Ca 2+ signaling underlying stimulus-secretion coupling in astrocytes.
TNFa Controls Docking and Speed of Exocytosis of Glutamate Vesicles in Cultured Astrocytes
We therefore went on to investigate whether TNFa acts downstream to P2Y1R-evoked [Ca 2+ ] i elevations, in the Ca 2+ dependent process leading to glutamate release from astrocytes. We initially turned to studies in cell cultures, where P2Y1R activation has been established to trigger glutamate release via vesicular exocytosis (Bowser and Khakh, 2007; Domercq et al., 2006) and where the underlying cellular events can be studied directly (Bezzi et al., 2004; Marchaland et al., 2008; Shigetomi et al., 2010) . To this end, we used total internal reflection fluorescence (TIRF) microscopy and a specific marker of glutamatergic vesicle exocytosis, VGLUT1pHluorin, the chimerical fluorescent protein formed by vesicular glutamate transporter-1 (VGLUT1) coupled to pHluorin (Balaji and Ryan, 2007; Marchaland et al., 2008; Voglmaier et al., 2006) . Even before studying the dynamics of P2Y1R-evoked exocytosis, we noticed a clear difference between WT and Tnf À/À astrocytes, in the number of VGLUT1-pHluorinexpressing vesicles present in the submembrane TIRF field, the so-called ''resident'' vesicles, thought to be docked to the plasma membrane Zenisek et al., 2000) . Thus, in Tnf À/À cells, ''resident'' vesicles, visualized by rapid alkalinizing NH 4 Cl pulses (Balaji and Ryan, 2007) , were about 50% less numerous than in WT cells (WT: 0.67 ± 0.08 vesicles/mm 2 ; n = 8 cells; Tnf À/À : 0.35 ± 0.02 vesicles/mm 2 ; n = 16 cells; p < 0.001; Figure 4A ). This defect was not due to a reduced overall number of glutamatergic vesicles in Tnf À/À astrocytes because the total VGLUT1-pHluorin fluorescence/cell under epifluorescence illumination was identical in Tnf À/À and WT cells by stimulating P2Y1R with 2MeSADP (10 mM, 2 s). Figure 4B shows that, in WT astrocytes, 2MeSADP produced a biphasic burst of exocytic events (456 ± 85; n = 12 cells) with the first peak occurring at $270 ms from the start of the stimulus and the second one at $580 ms. The number of fusion events, rare before the stimulus (4 ± 2 events/s), increased dramatically upon 2MeSADP application (198 ± 89.4 events/s during the stimulus) and returned to basal level in about 3 s. In Tnf À/À astrocytes, the effect observed was profoundly different ( Figure 4C ). Based on our previous glutamate release measures (Domercq et al., 2006) , we expected to see a decreased number of exocytic events. In contrast, to our surprise, P2Y1R activation evoked the (left) and after (right) TNFa incubation. Black histograms: ''resident'' vesicles; gray histograms: ''newcomer'' vesicles. Notice that in the absence of TNFa, and similar to (D), the two rapid phases of the burst were abolished (30 ± 9.2 events/s during the stimulus) and the fusion events reached a small peak around 4 s. There was no temporal segregation between events attributable to ''resident'' and ''newcomer'' vesicles. When Tnf À/À astrocytes were preincubated with TNFa (30 pM, 3-8 min), the exocytic response was reconverted to a rapid biphasic burst like in WT cultures (181.6 ± 60 events/s during the stimulus; first peak: 200-300 ms; second peak: 400-600 ms; n = 7 cells) and fusions of ''residents'' (first peak) preceded those of ''newcomers'' (second peak). Each histogram represents the mean number (±SD) of fusion events counted in a 100 ms long frame. See also Figure S3 .
same number of events as in WT astrocytes (504 ± 74; n = 20 cells). However, their temporal distribution was completely different, highlighting a dramatic slowing-down and desynchronization of the release process. No rapid biphasic burst was observed, just a small peak of fusion events that occurred at 3.8-4.2 s, i.e., more than 10-fold slower than the initial peak in WT astrocytes. In fact, the majority of the fusion events occurred sparsely in time (33.8 ± 23.8 events/s during the stimulus) and over a prolonged (8 s) period. Noteworthy, this dramatic temporal alteration was not just a peculiarity of P2Y1R-evoked glutamate exocytosis, because when we tested the effect of stromal cell-derived factor-1a (SDF-1a/CXCL12, 3 nM), a chemokine CXCR4 receptor agonist known to induce glutamate release from astrocytes (Bezzi et al., 2001; Calì et al., 2008) , the agent not only evoked in WT astrocytes an exocytosis process with temporal characteristics analogs to the 2MeSADP-evoked process, but also produced in Tnf À/À astrocytes the same pattern of temporally altered fusions seen with the P2Y1R agonist ( Figures S3A and S3B ). That such temporal alterations depend specifically on the absence of constitutive TNFa was demonstrated by experiments in which we stimulated Tnf À/À astrocytes with 2MeSADP twice, first in the absence of TNFa and then after preincubating the cells with the cytokine (30 pM, 3-8 min). Figure 4D shows that addition of TNFa converted the slow and desynchronized response to the P2Y1R agonist into a rapid biphasic exocytic burst with events' distribution similar to that seen in WT cultures (550 ± 72 fusion events; 239.2 ± 76 events/s during the stimulus; first peak: $260 ms; second peak: $510 ms; n = 7 cells). In parallel control experiments, in which TNFa was not added between the first and second 2MeSADP pulse, the P2Y1R agonist produced twice the same slow response ( Figure S3C ). Interestingly, incubation of Tnf À/À astrocytes with TNFa had an additional effect, i.e., it increased the number of ''resident'' vesicles in basal condition, restoring the levels seen in WT astrocytes ( Figure 4D , insets), suggesting that this basal defect and the one observed when evoking secretion may both depend on loss of the same TNFa-dependent regulatory mechanism. We therefore devised experiments to better understand such a mechanism. By doubly transfecting glutamatergic vesicles with a marker of the vesicle membrane (VGLUT1mCherry) together with VGLUT1pHluorin, we could distinguish two vesicular pools undergoing exocytosis upon P2Y1R stimulation: the ''resident'' pool (vesicles present in the TIRF field before the stimulus, in principle docked) and the ''newcomers'' pool (vesicles whose mCherry signal appeared in the TIRF field after the stimulus, which represent undocked vesicles arriving from the cytosol Zenisek et al., 2000] ). In WT astrocytes (data not shown) and in Tnf À/À astrocytes incubated with TNFa, ( Figure 4E ) the two pools underwent exocytosis in a clear biphasic temporal sequence: during the first phase (0-400 ms) most of the fusing vesicles belonged to the ''resident'' pool (80.6%, n = 7 cells), whereas during the second phase (500 ms-2 s), to the ''newcomers'' pool (82.5%). This temporal segregation reflects the different readiness to fusion of the two pools, in particular the fact that most ''resident'' vesicles, contrary to ''newcomers,'' have already undergone the docking steps and are ready for fusion (i. However, in Tnf À/À astrocytes, the situation was very different.
Events attributable to ''residents'' decreased in percentage (20% instead of 40%; n = 3680 vesicle fusions analyzed, n = 7 cells). Moreover, importantly, events due to ''residents'' and ''newcomers'' occurred randomly, without the expected temporal segregation. This indicates that even the residual ''resident'' pool seen in Figure 4A is defective in Tnf À/À astrocytes, because it is not ready/competent to fuse. Most likely, these vesicles dock only transiently and, like all the others, in the absence of TNFa are hampered in reaching the stage of functional docking allowing them to undergo rapid fusion (Toonen et al., 2006) . We conclude that constitutive TNFa is necessary for the correct reception of glutamatergic vesicles to release sites, a precondition for efficient exocytosis upon stimulation.
In parallel TIRF experiments, we studied local submembrane Ca 2+ events, previously shown to be temporally locked to exocytic events . Indeed, in WT astrocytes, 2MeSADP stimulation induced a burst of submembrane Ca 2+ events whose temporal pattern mirrored the one of VGLUT1-pHluorin fusion events, with two peaks of Ca 2+ events, each one slightly preceding the corresponding peak of vesicular fusions ( Figure 4B, inset) . Importantly, and in full agreement with the observations in situ, this pattern was totally preserved in Tnf À/À astrocytes ( Figure 4C , inset), further confirming that TNFa does not act on the coupling between GPCR and [Ca 2+ ] i elevation, and indicating that this step of gliotransmission can be perfectly normal while the downstream signaling is dramatically defective.
Lack of TNFa Shifts the Dynamic Competition between Astrocyte Glutamate Release and Uptake
The above results, indicating a tonic control of TNFa on P2Y1R-evoked astrocyte glutamate release, seem at odds with two previous observations that (1) TNFa itself induces glutamate release from astrocytes (Bezzi et al., 2001; Rossi et al., 2005) and (2) P2Y1R-evoked glutamate release is strongly reduced in Tnf À/À preparations (Domercq et al., 2006) . The first point is explained by dose dependency of the TNFa effects ( Figure 5A ). Indeed, when tested at the concentration used in our previous studies (1.8 nM), the cytokine induced exocytic fusion of VGLUT1pHluorin-expressing vesicles. However, this direct effect was observed only at TNFa concentrations R300 pM, 10-fold higher than the concentration reconstituting normal P2Y1R-evoked exocytosis in cultured Tnf À/À astrocytes. The second point is explained by competition between release and uptake of glutamate from astrocytes, which causes reduced detection of the P2Y1R-evoked glutamate release in Tnf À/À preparations ( Figure 5B ). This competition was revealed by comparing 2MeSADP-evoked release in the presence and absence of the uptake blocker, DL-threo-beta-benzyloxyaspartate (TBOA). Like in previous studies, we measured glutamate in Tnf À/À cultures by adding the metabolic enzyme glutamic dehydrogenase (GDH) to the medium (Bezzi et al., 2004; Nicholls et al., 1987) . TBOA was then added at a concentration (25 mM) not affecting the basal glutamate level. In spite of this, TBOA profoundly affected detection of P2Y1R-evoked glutamate release which, in its presence, was increased by $10-fold (from 0.058 ± 0.008 to 0.56 ± 0.1 nmol/mg prot; n = 5 and 7; p < 0.05 unpaired t test) up to levels comparable to those measured from WT astrocytes. In contrast, release in WT cultures did not vary significantly in the absence or presence of the uptake blocker (without TBOA: 0.60 ± 0.12; with TBOA: 0.78 ± 0.16 nmol/mg prot; n = 6 and 4; n.s., unpaired t test). The most logical explanation for these observations is that, in Tnf À/À astrocytes with defective exocytosis, P2Y1R stimulation induces much less glutamate release/time unit than in WT astrocytes, which favors more rapid scavenging of the released amino acid by glutamate transporters. As aconsequence, less glutamate becomes available to GDH, which binds the amino acid with lower affinity than the transporters (Plaitakis and Zaganas, 2001), resulting in a reduced detection of release. Importantly, we previously reported a similar strong reduction of P2Y1R-evoked glutamate release in hippocampal Tnf À/À slices (Domercq et al., 2006) . Therefore, the same problem, competition of defective release by uptake, could also occur in situ and ultimately prevent activation of pre-NMDAR. Alternatively, uptake efficiency could increase in Tnf À/À preparations, producing the same final result. To verify this latter possibility we studied synaptically evoked transporter currents (STCs) in situ (Diamond, 2005) . We stimulated PP afferents and recorded STCs from whole-cell patch-clamped astrocytes in the dentate ML ( Figure 5C ; see Experimental Procedures). By comparing recordings in WT and Tnf À/À slices, we failed to find differences in any of the parameters analyzed (total charge transfer, currents' rise-time and t 50 , Figures 5C and 5D ). Therefore, in the absence of TNFa, ML astrocytes maintain the same number of functional glutamate transporters and take up the same amount of glutamate as in WT preparations, excluding astrocytic glutamate uptake as direct target of the TNFa-dependent control of gliotransmission.
Limiting Glutamate Uptake Restores Synaptic Efficacy of Gliotransmission in the Absence of TNFa
If P2Y1R stimulation fails to increase mEPSC frequency at GC synapses in Tnf À/À slices because of competition between defective astrocyte glutamate release and uptake, then blockade of the latter could be compensatory and artificially restore the synaptic effect lost by the defective release and, thereby, unmask its occurrence. To directly test this possibility, we added TBOA to hippocampal slices from Tnf À/À mice. At first, we checked the effects of the uptake blocker on basal activity in GCs. When applied at a subsaturating concentration (25 mM) , TBOA produced a clear change in and presence (B2 and B4) of TBOA (25 mM, about 5 min of incubation). In WT astrocytes, the 2MeSADP-evoked glutamate release detected in the absence and presence of TBOA is similar (n = 6 and n = 4, respectively; p > 0.05 unpaired t test). In contrast, in Tnf À/À astrocytes, the amount of 2MeSADP-evoked release detected in the absence of TBOA (n = 5) is significantly less than in its presence (n = 7; p < 0.05 unpaired t test). Notice that TBOA per se has no effects on the glutamate levels detected in the cultures. (C) Left: synaptically evoked transporter current (STC). The representative trace is obtained by recording the current response to PP stimulation in a ML astrocyte and by subtracting to it a trace of the same current in the presence of the transporter antagonist TBOA (100mM, STC + sustained current). By blocking the transporter current, TBOA reveals a sustained component of the synaptically evoked current, reflecting a sustained potassium conductance (Diamond, 2005) . 
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TNFa Controls the Astrocytic Input to Synapses mEPSC activity, with no other detectable effect on membrane currents (which were instead affected using 100 mM of the uptake blocker, data not shown). Notably, TBOA selectively increased the frequency of mEPSC events (+52% ± 13%; p < 0.001, n = 10 cells; Figure 6A ), without changing their amplitude and kinetics. This effect was fully reversed by ifenprodil ( Figure 6A ), indicating that enhanced ambient glutamate activates pre-NMDAR. We then tested the effect of P2Y1R stimulation in the presence of the uptake blocker. Despite the TBOA-induced enhancement of basal mEPSC frequency in GCs, subsequent application of 2MeSADP in the continued presence of TBOA, produced a further significant increase in frequency (+47% ± 9%; p < 0.001; n = 18 cells) without changing amplitude of the miniature events ( Figure 6B ). Blocking NMDA receptors with ifenprodil in the presence of both 2MeSADP and TBOA fully reversed the overall increase in mEPSC frequency produced by the two agents ( Figure 6B ). These data indicate that, in Tnf À/À mice, inhibition of glutamate uptake by TBOA produces two effects on mEPSC frequency in GCs, both mediated by activation of presynaptic NR2B-containing NMDARs: (1) an increase in the basal frequency of the events and (2) a further 2MeSADP-dependent increase, resembling the effect produced by the P2Y1R agonist in WT mice. Taking all our data together, the most plausible explanation for the latter effect is that, in situ like in culture, astrocytic glutamate release is deregulated in the absence of TNFa. Thus, although astrocytic glutamate in Tnf À/À slices fails to induce pre-NMDAR-dependent modulation, reappearance of this type of effect in the presence of TBOA confirms that the transmitter is indeed released upon P2Y1R stimulation, but defectively and, because of competing uptake, it does not reach an extracellular concentration sufficient to activate pre-NMDAR.
DISCUSSION TNFa Dependency of Gliotransmission
Here, we show that the neuromodulatory action of astrocytes at dentate GC synapses, via Ca 2+ -dependent glutamate release and pre-NMDAR activation, is controlled by TNFa, i.e., that constitutive levels of the cytokine, estimated to be in the low picomolar range, need to be present for the neuromodulation to occur. TNFa controls steps in the stimulus-secretion coupling mechanism in astrocytes downstream of GPCR-evoked [Ca 2+ ] i elevations. In particular, we identified, in cultured astrocytes from Tnf À/À mice, a defect in the functional docking of glutamatergic vesicles, which decreases their readiness to fuse and dramatically slows down the kinetics of evoked exocytosis. As a consequence, slowly released glutamate is more rapidly taken up by competing uptake. This type of defect plausibly explains why astrocyte glutamate release fails to activate pre-NMDAR and loses synaptic efficacy in Tnf À/À slices and why use of low concentrations of the uptake blocker TBOA in this preparation can be compensatory and ''restore'' the neuromodulatory effect ( Figure 7 ).
Levels of Activity Triggering Modulatory Gliotransmission at PP-GC Synapses
In the present study, we triggered gliotransmission by stimulation of P2Y1R, a native GPCR, with a pharmacological agonist, 2MeSADP, and used mEPSC activity as a readout of the evoked GC comparing the effect of subsequent additions of 25 mM TBOA (TBOA), 10 mM 2MeSADP in the presence of TBOA (TBOA + 2MeSADP) and 3 mM ifenprodil in the presence of the two former agents (TBOA + 2MeSADP + ifenprodil). Right: mEPSC mean frequency increases upon TBOA application; subsequent 2MeSADP stimulation produces a further significant increase, and addition of ifenprodil counteracts both effects, bringing the frequency back to control level. None of the treatments affected mEPSC amplitude (n = 18 GCs). The effect of 2MeSADP in presence of TBOA was observed in 10/18 Tnf À/À GCs (+47% ± 9%, p < 0.001). ***p < 0.001, **p < 0.01, *p < 0.05, one-way ANOVA + Scheffé test for multiple comparisons. Error bars: SEM.
neuromodulatory effect (that this is via astrocytic Ca 2+ signaling was confirmed by sensitivity of neuromodulation to the Ca 2+ buffer BAPTA introduced exclusively into astrocytes). This experimental paradigm was selected for two main reasons: because it induces neuromodulation in a highly reproducible manner, well adapted to study the role of TNFa, and because in these conditions, i.e., blocking action potentials, the P2Y1R-dependent pathway is not endogenously activated, which would have complicated interpretation of the results. Indeed, P2Y1R-dependent gliotransmission at PP-GC synapses is a physiological modulatory mechanism triggered in response to action potential-dependent synaptic transmission (Jourdain et al., 2007) but not to action potential-independent, spontaneous synaptic release events. The evidence for this comes from the observation that blocking the P2Y1R-dependent pathway at different levels (P2Y1R, astrocyte [Ca 2+ ] i elevation, pre-NMDAR), led, in all cases, to a reduction in basal EPSC frequency when the synaptic activity was recorded in the absence of TTX (sEPSC; Jourdain et al., 2007) . In contrast, no effect was produced if TTX was present and action potentials were abolished (mEPSC; Figure 1 ). In keeping, the absence of TNFa in Tnf À/À slices or in WT slices incubated with sTNFR, while abolishing 2MeSADP-evoked neuromodulation, did not produce any change in basal mEPSC frequency. Intriguingly, we recently observed that action potentials in the hippocampal dentate gyrus synchronize several small ($1 mm) ''Ca 2+ microdomains'' in astrocytic processes (most likely representing the random local responses to single synapse release events) and produce stronger and spatially larger (several mm) [Ca 2+ ] i elevations, in part mediated by P2Y1R (Chuquet et al., 2010) . This latter, action potential-evoked Ca 2+ activity, not the former, is associated to the neuromodulatory response of the astrocyte. Therefore, it seems key for physiological astrocyte synaptic modulation to occur, that not just individual ''Ca 2+ microdomains'' but larger process segments are synchronously active, most likely to release glutamate in sufficient amounts to activate nearby pre-NMDAR. Hence, we can hypothesize that synchronous [Ca 2+ ] i increase in large domains of the astrocyte process leads to synchronous glutamate release from different release sites.
Kinetic Requirements of Glutamate Release from Astrocytes: The Role of TNFa Overall, our data suggest that when constitutive TNFa is removed P2Y1R-evoked gliotransmission loses its synaptic efficacy because of a loss of synchronicity, not at the level of [Ca 2+ ] i elevations, but at the ensuing glutamate release process. The mechanistic studies in cultured astrocytes, where P2Y1R stimulation induces exocytosis of glutamatergic vesicles (Bowser and Khakh, 2007; Domercq et al., 2006) , point to a specific role of the cytokine in promoting functional docking of the vesicles at release sites and, consequently, in permitting their immediate fusion upon stimulation. A characteristic of GPCR-evoked exocytosis in vitro is that release-ready vesicles (those ''residents'' in the TIRF field) undergo fusion rapidly (peak at $300 ms) and in a highly synchronous manner (Bergami et al., 2008; Bezzi et al., 2004; Domercq et al., 2006; Marchaland et al., 2008) . However, when constitutive TNFa is missing, all vesicles, including the ''resident'' ones, are not ready to fuse immediately upon stimulation. Ultimately, they do fuse, but randomly in time (small peak at $4 s) and over a much longer period than when the cytokine is present. Interestingly, these functional defects are reminiscent of those reported in neurosecretory cells upon interfering with the molecular machinery promoting vesicle docking (reviewed in Verhage and Sørensen, 2008) .
Could altered vesicular exocytosis, as observed in cultured Tnf À/À astrocytes, underlie the defect of glutamate release observed in situ? Although no conclusive evidence exists yet, we previously reported that the process in situ is sensitive to exocytosis blockers (Domercq et al., 2006; Jourdain et al., 2007) . Moreover, we showed that VGLUT-expressing synapticlike microvesicles (SLMV) are present in the perisynaptic processes of astrocytes in the dentate ML (Bezzi et al., 2004) , mostly laying in proximity (<150 nm) of NR2B subunits signaling pre-NMDAR in adjacent excitatory nerve terminals (Jourdain et al., 2007) . Based on this information, we could Left: in the presence of constitutive TNFa (red diamonds), astrocyte vesicles containing glutamate (Glut., blue dots) are functionally docked at putative active zones on the plasma membrane of a perisynaptic astrocytic process. When ATP (yellow pentangles) is released (1) from GC synapses or the astrocytes (Jourdain et al., 2007) , it activates P2Y1 receptors (2) and causes Ca 2+ release from the internal stores in the astrocyte microcompartment (3). This in turn triggers fusion of the astrocyte vesicles in proximity of presynaptic NR2B containing NMDARs (4), eventually causing an increase in excitatory synaptic activity (5). Right: in the absence of TNFa, astrocytic glutamatergic vesicles are not correctly docked and ready to fuse. Therefore, when ATP triggers the usual signal-transduction in astrocytes, glutamate release occurs slowly and asynchronously and is scavenged by glutamate transporters before reaching pre-NMDA receptors to induce synaptic modulation.
hypothesize that pre-NMDAR activation requires glutamate released by the fusion of more than one such astrocytic vesicle, which would explain why loss of synchronicity in the exocytosis of glutamatergic vesicles critically affects the activation state of NMDAR. ] i elevation in astrocytes, even when produced by stimulation of the appropriate GPCR, is not ''necessary and sufficient'' for functional gliotransmission to occur (Araque et al., 1998) if a downstream control mechanism is altered. Thus, we identify the existence of permissive/homeostatic factors like TNFa that control stimulus-secretion coupling in astrocytes and its synaptic effects independently of, and in addition to, [Ca 2+ ] i elevations. We believe that this finding represents a relevant contribution to the understanding of the process of gliotransmission, particularly in view of recent conflicting results. Indeed, parallel investigations using different experimental paradigms succeeded or failed in detecting an astrocytic control on synaptic transmission and plasticity (Agulhon et al., 2010; Fellin et al., 2004; Fiacco et al., 2007; Henneberger et al., 2010; Perea and Araque, 2007) . While the present debate focuses on the required characteristics of astrocytic [Ca 2+ ] i elevations for the control to occur (Hamilton and Attwell, 2010; Kirchhoff, 2010) , our findings call for attention also to the role of additional factors.
Gliotransmission
TNFa Controls Excitatory Transmission: Dose Dependency, Pre-and Postsynaptic Targets Our study reveals a complexity and dose dependency of the TNFa effects on astrocyte glutamate release and on mEPSC activity in general. The effects on P2Y1R-or CXCR4-evoked glutamate release observed in the present study, which affect presynaptic excitatory function, depend on the presence of constitutive TNFa and are ''reconstituted'' in Tnf À/À astrocytes by adding low picomolar concentrations of the cytokine. However, in line with our previous observations (Bezzi et al., 1998; Bezzi et al., 2001) , at higher (nanomolar) concentrations, the cytokine induces exocytosis of glutamatergic vesicles directly, suggesting that its impact on excitatory transmission may change at these concentrations (see below). Incubation of Tnf À/À slices with low picomolar levels of TNFa has an additional effect on the amplitude of mEPSC events, which is slightly but significantly increased by the presence of the cytokine. This effect, independent of astrocyte P2Y1R-dependent glutamate signaling, is reminiscent of the effect mediating synaptic scaling in WT mice via surface insertion of postsynaptic AMPAR subunits (Stellwagen and Malenka, 2006) . This observation suggests that TNFa exerts multiple, possibly coordinated, regulatory actions at excitatory synapses, which apparently converge in strengthening synaptic connectivity. Intriguingly, we did not find that basal mEPSC amplitude was reduced in Tnf À/À slices compared to WT slices (see also Beattie et al., 2002; Kaneko et al., 2008; Stellwagen and Malenka, 2006) . This is probably because TNFa mediates exclusively the scalingup of synapses, a phenomenon in which synapses adapt to increased TNFa levels, whereas the opposite scaling-down phenomenon might be controlled by TNFa-independent mechanisms (Aizenman and Pratt, 2008; Cingolani et al., 2008) .
Relevance of the TNFa-Dependent Control of the Astrocytic Input to Excitatory Synapses Our study introduces the concept of regulation of the astrocytic input to synapses by ambient factors like TNFa. This is particularly relevant also because we show that the cytokine displays concentration-dependent effects on astrocytic glutamate release, going from a permissive/gating action to direct stimulation. We do not know if these represent mechanistically distinct modes of action or, perhaps more probably, a gradual shift in the effects of TNFa. In the latter case, we could hypothesize that, even at gating levels, small fluctuations in TNFa concentrations, could subtly modify the astrocytic input to synapses. Physiological processes like sleep have been proposed to be regulated by local variations in TNFa levels in the brain related to the sleep-wake cycle, and sleep deregulation can be induced by injections of the cytokine (Imeri and Opp, 2009; Krueger, 2008) . Therefore, an intriguing hypothesis is that the TNFa control of gliotransmission is involved in sleep homeostasis together with other glial pathways already identified Halassa et al., 2009) . Moreover, the levels of TNFa are subject to dramatic changes in pathological conditions when microglia releases large amounts of the cytokine. We have already shown in a cell culture model that in such a situation, TNFa strongly amplifies glutamate release from astrocytes (Bezzi et al., 2001) . We can then hypothesize that a pathologyinduced switch in the TNFa levels may have an important impact on the astrocytic input to synapses, notably in the presynaptic regulation of neuronal activity in the PP-GC hippocampal synaptic circuit. This may perturb the normal control by this circuit on critical processes such as memory formation and physiological limbic system excitability.
EXPERIMENTAL PROCEDURES
TNFa-Deficient Mice
Mice homozygous for the null mutant TNFa (Tnf À/À ) allele were generated and maintained on a C57BL/6J background as described in the original study (Pasparakis et al., 1996) . Knockout animals were housed under specific pathogen-free conditions together with age-and sex-matched WT mice.
Hemibrain Slices
Hemibrain horizontal slices (400 mm) containing intact perforant path afferents (Staley and Mody, 1991) were obtained from 18-to 23-day-old C57/BL6 male and female WT and Tnf À/À mice and maintained in 95% O 2 and 5% CO 2 -gassed artificial cerebrospinal fluid (ACSF), containing (in mM): 118 NaCl, 2 KCl, 2 MgCl 2 , 2.5 CaCl 2 , 25 NaHCO 3 , 1.2 NaH 2 PO 4 , 10 glucose, and 0.1 picrotoxin at pH 7.4. In some experiments astrocytes were loaded with sulphorhodamine 101 (SR-101, 5mM) by incubating the slices at 37 C with the dye for 15 min.
Patch-Clamp Recordings
Details are provided in the Supplemental Experimental Procedures.
Currents Analysis
Currents have been analyzed essentially as reported in Jourdain et al. (2007) ; see Supplemental Experimental Procedures.
Astrocyte Cultures and TIRF Imaging Experiments
Astrocyte cultures were obtained from WT and Tnf À/À newborn mice and prepared essentially as described (Bezzi et al., 2001; Domercq et al., 2006) ; TIRF imaging experiments were performed essentially as described ; see Supplemental Experimental Procedures.
Two-Photon Ca 2+ Imaging In Situ
In situ Ca 2+ imaging experiments in single astrocytes were performed using a Prairie Technology Ultima (Madison, WI) two-photon laser scanning microscope consisting of an Olympus BX61WI with a Prairie galvanometer scanning system and a 603 water immersion objective lens (numerical aperture: 0.9; Olympus Optical LUMPlan FI/IR). Fluorescence emission was directed by a 700 longpass dichroic mirror (LPDM), divided with a 575 LPDM into green and red channels and further restricted with 607/45 nm and 525/70 nm filters placed before the green and red photomultiplier, respectively. ''Dodt contrast'' images were generated by spatially filtering the forward scattered IR laser light with a Dodt tube and detected by an additional photomultiplier tube. The light source was a pulsed laser (Chameleon-XR, Coherent, Santa Clara, CA) tuned to 815 nm for calcium and ''Dodt contrast'' imaging and 890 nm for the sole morphology acquisition with TxR fluorescence. Crop of the image at the region of interest allowed both high spatial (5 pixels/mm) and temporal (frame rate, 10-17 Hz) resolution in frame scan mode (dwell time, 2.4 ms). Using these conditions, the laser power could be limited to 9-13 mW (measured before the objective) to minimize the potential effect of illumination on [Ca 2+ ] i as reveled by no change of Fluo-4 fluorescence between the first and the last 10 s of the imaging sequence. Focal and short 2MeSADP puffs (5 ms, 10 mM) to detect local [Ca 2+ ] i elevations were delivered by low-pressure ejection (4 psi) via a PV830 Pneumatic PicoPump (WPI). By simultaneous acquisition of florescence and high-contrast transmitted-light imaging (Dodt contrast) we were able to position the ejection pipette within 3-8 mm from the imaged astrocyte process, paying attention to not enter in the arbor of the patched astrocyte. In some experiments, we verified the spatial diffusion of the drug ($10-15 mm diameter) including TxR in the ejection pipette. All solutions contained TTX 1 mM and Picrotoxin 100 mM.
Image Analysis
The structure of the process was extracted from the rest of the image (red channel, TxR fluorescence) by a segmentation paradigm combining tools of mathematical morphology implemented in Matlab. The process was then subdivided in many contiguous subregions (SRs, ] i elevation invaded more than one SR, kinetics of the event were calculated on the first responding SR.
Recordings showing any drift (x, y, or z) were discarded. Traces were subjected to median filter before analysis.
Other Imaging Experiments In Situ
In a set of electrophysiological experiments in hippocampal slices, BAPTA was dialyzed into the astrocytes. To indirectly follow the process, we monitored diffusion of a fluorescent dye, Alexa 488 hydrazide or Alexa 594, from the whole-cell patched astrocyte to the astrocytic syncytium in the dentate ML. Within 15-30 min tens of gap junction-coupled astrocytes were labeled by the dye (Shigetomi et al., 2008) . After removal of the pipette, florescence in the syncytium remained stable for at least 1 hr and during the whole experiment. Images were normally observed on an Olympus BX51WI microscope (203 water-immersion objective). The excitation light beam (488 nm/590 nm, monochromator, Visichrome, Visitron; controlled by Metafluor software, Universal Imaging) was introduced through the objective by a long-pass filter (Olympus U-N31001); fluorescence emission was collected (cooled CCD camera, CoolSNAP-HQ, Roper Scientific) with a 1 frame/s acquisition rate. Some of the experiments ( Figures 1A-1D ) were performed under a two-photon laser scanning microscope with a 403 water-immersion objective. For in situ visualization of astrocytes and granule cells loaded respectively with SR-101 and Alexa 488, or Alexa 594 and Alexa 488, excitation was provided at 800-830 nm.
Enzymatic Assay of Endogenous Glutamate Release
Efflux of endogenous glutamate from cell cultures was monitored in continuous by use of an enzymatic assay as previously described (Bezzi et al., 1998) ; see Supplemental Experimental Procedures.
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